Literature DB >> 28936538

Cool it or not but based on what?

B Yildiz1, M Tez2.   

Abstract

Mesh：

Year:  2017        PMID： 28936538     DOI： 10.1007/s00068-017-0837-z

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN： 1863-9933            Impact factor:   3.693


× No keyword cloud information.
  3 in total

1.  TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis.

Authors:  Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; Harumi Gomi; Masahiro Yoshida; Toshihiko Mayumi; Fumihiko Miura; Dirk J Gouma; O James Garden; Markus W Büchler; Seiki Kiriyama; Masamichi Yokoe; Yasutoshi Kimura; Toshio Tsuyuguchi; Takao Itoi; Toshifumi Gabata; Ryota Higuchi; Kohji Okamoto; Jiro Hata; Atsuhiko Murata; Shinya Kusachi; John A Windsor; Avinash N Supe; SungGyu Lee; Xiao-Ping Chen; Yuichi Yamashita; Koichi Hirata; Kazuo Inui; Yoshinobu Sumiyama
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027

2.  Admission after the gold interval in acute calculous cholecystitis: Should we really cool it off?

Authors:  M A Bozkurt; M Gönenç; K D Peker; H Yırgın; H Alış
Journal:  Eur J Trauma Emerg Surg       Date:  2016-01-07       Impact factor: 3.693

3.  TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos).

Authors:  Seiki Kiriyama; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Toshihiko Mayumi; Henry A Pitt; Dirk J Gouma; O James Garden; Markus W Büchler; Masamichi Yokoe; Yasutoshi Kimura; Toshio Tsuyuguchi; Takao Itoi; Masahiro Yoshida; Fumihiko Miura; Yuichi Yamashita; Kohji Okamoto; Toshifumi Gabata; Jiro Hata; Ryota Higuchi; John A Windsor; Philippus C Bornman; Sheung-Tat Fan; Harijt Singh; Eduardo de Santibanes; Harumi Gomi; Shinya Kusachi; Atsuhiko Murata; Xiao-Ping Chen; Palepu Jagannath; SungGyu Lee; Robert Padbury; Miin-Fu Chen; Christos Dervenis; Angus C W Chan; Avinash N Supe; Kui-Hin Liau; Myung-Hwan Kim; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.